In the Treg context, CCR2, CCR4 and CCR6 have previously been shown to be up‐regulated in Tregs migrating to non‐lymphoid tissues or sites of inflammation,54 and this may be the primary basis of their increase in the atherosclerosis phenotype. The gene discussed is CCR2; the disease is atherosclerosis.